July 13, 2012
Co founder of Labonnet, CEO, Since 2006
Molecular Diagnostics Medical IT Current stage - beta completed. After thorough validation of the method in hundreds of labs in a standardization project of the EU.
I inevested only in my own company. I would not define myself 'investor'.
In the last 10 years the team I have been leading took an idea all the way from the lab bench to (soon) inclusion in the EU guidelines for in-vitro medical diagnostics.